AYŞE BETÜL BİNGÖL

Ms. AYŞE BETÜL BİNGÖL

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 July 2025 in Progress in Additive Manufacturing
Verified
Journal Article
Closed access
PDF file
MMMohammad Moghaddasi
Mohammad Moghaddasi
BOBüşra OKTAY
Büşra OKTAY
ABAYŞE BETÜL BİNGÖL
AYŞE BETÜL BİNGÖL
RYReyhan YANIKOĞLU
Reyhan YANIKOĞLU
Fatih CiftciFatih Ciftci
Fatih Ciftci
Cem UstundagCem Ustundag
Cem Ustundag

2 August 2025 in Journal of Applied Polymer Science
Verified
Journal Article
Closed access
IAIsraa F. Abdulazez
Israa F. Abdulazez
BOBüşra OKTAY
Büşra OKTAY
HYHilal Yilmaz
Hilal Yilmaz
ABAYŞE BETÜL BİNGÖL
AYŞE BETÜL BİNGÖL
AKAlpay Kose
Alpay Kose
Cem UstundagCem Ustundag
Cem Ustundag

31 July 2025 in Macromolecular Materials and Engineering
Verified
Journal Article
Open access
ABAYŞE BETÜL BİNGÖL
AYŞE BETÜL BİNGÖL
CKCanan Yağmur KARAKAŞ
Canan Yağmur KARAKAŞ
MYMERYEM AKKURT YILDIRIM
MERYEM AKKURT YILDIRIM
Mert Akin InselMert Akin Insel
Mert Akin Insel
AZAli Can Zaman
Ali Can Zaman
Cem UstundagCem Ustundag
Cem Ustundag
This study introduces a multilayered biofunctional tumor dressing designed for localized treatment after tumor resection. The system incorporates three therapeutic agents: doxorubicin (DOX) for anticancer action, amoxicillin (AMOX) for antibacterial protection, and ibuprofen (IBU) for anti‐inflammatory support. These drugs were loaded into polyvinyl alcohol (PVA) and polycaprolactone (PCL) matrices via a hybrid method combining 3D printing, electrospinning, and electrospraying. FTIR, SEM, and optical microscopy confirmed structural integrity. in vitro release at pH 7.4 and 37°C showed rapid DOX and AMOX release within 240 min, while IBU exhibited sustained release over 120 h. Mathematical modeling (zero‐order, first‐order, Higuchi, and Korsmeyer–Peppas) indicated diffusion‐driven, matrix‐controlled kinetics. Encapsulation efficiencies exceeded 98%, affirming fabrication reliability. Antibacterial tests showed stronger activity against Staphylococcus aureus than Escherichia coli . Cytotoxicity results demonstrated selective toxicity, with 42.86% viability in CCD1072‐Sk fibroblasts and lower survival in MCF‐7 (25.63%) and A549 (23.76%) cancer cells. This multifunctional dressing enables spatial and temporal control over drug release to effectively manage residual tumor cells, infection, and inflammation, offering a promising strategy for postoperative cancer therapy with minimized systemic side effects.


2 September 2025
Verified
Book Chapter
Closed access
PDF file
ABAYŞE BETÜL BİNGÖL
AYŞE BETÜL BİNGÖL
BOBüşra OKTAY
Büşra OKTAY
IAIsraa F. Abdulazez
Israa F. Abdulazez
AOAysel Oktay
Aysel Oktay
HYHilal Yilmaz
Hilal Yilmaz
Cem UstundagCem Ustundag
Cem Ustundag
This chapter explores the potential of 3D bioprinting in tissue engineering (TE), emphasizing its contribution to the advancement of regenerative medicine. It begins with a brief introduction to TE followed by an exploration of how 3D bioprinting has become a key technology in this space. The primary goal of the chapter is to examine the techniques, materials, challenges, and future possibilities of 3D bioprinting for creating tissue scaffolds. The chapter first explains the fundamentals of 3D bioprinting, covering its basic principles and tracing its development over time. It then moves on to the critical role of biopolymers—such as collagen, gelatin, and alginate—which are commonly used to construct scaffolds. Their properties, including biocompatibility, biodegradability, and mechanical strength, are discussed, highlighting why these materials are chosen for TE applications. Next, the focus shifts to the design and modeling of scaffolds, showing how medical imaging and computer-aided design (CAD) are used to create tissue-specific structures. Different bioprinting techniques, like extrusion, inkjet, and laser-assisted printing, are compared, and the formulation of bioinks—which play a vital role in cell encapsulation and tissue growth—is examined in detail. The chapter also highlights real-world bioprinting applications, featuring examples like skin, bone, and vascular grafts. It reviews the current successes as well as the limitations, particularly in areas like vascularization and scaffold degradation. In closing, the chapter addresses the technical, biological, and ethical challenges facing 3D bioprinting, along with the regulatory issues that will shape its future. It also explores the exciting possibilities ahead, outlining potential breakthroughs that could push this technology to new heights in medicine and TE. The conclusion summarizes the chapter's key points, emphasizing the long-term impact that 3D bioprinting may have on the future of healthcare. <!----> <!----> <!----> <!---->

18 August 2026 in Polymer Bulletin
Verified
Journal Article
Closed access
PDF file
DADilek Aygün
Dilek Aygün
AKAlpay Köse
Alpay Köse
DBDilruba Baykara
Dilruba Baykara
AKAnıl Tevfik Koçer
Anıl Tevfik Koçer
ZSZeynep Sünbül
Zeynep Sünbül
Cem UstundagCem Ustundag
Cem Ustundag